Chronic activation of central α2-adrenoceptors prevents hypertension in DOCA-salt rats

Autonomic Neuroscience: Basic and Clinical

Volumn 82, Issue 3, 2000, Pages 146-153

  Cabral, Antonio Melo ^a   Da Silva, Ilce Ferreira ^a   Gardioli, Catia Rocha ^a   Menegaz, Rubia Grecco ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

2 Adrenoceptor; DOCA salt hypertension; Renal excretory function; Renal nerve activity; Urinary sodium excretion; Xylazine; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; DEOXYCORTICOSTERONE ACETATE; SODIUM; SODIUM CHLORIDE; SOYBEAN OIL; WATER; XYLAZINE; YOHIMBINE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE SEVERITY; DIURESIS; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HEART RATE; HYPERTENSION; KIDNEY NERVE; MALE; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM RETENTION; SODIUM URINE LEVEL;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMAL; BLOOD PRESSURE; DESOXYCORTICOSTERONE; HEART RATE; HYPERTENSION, RENAL; INJECTIONS, INTRAVENTRICULAR; KIDNEY; MALE; NEPHRECTOMY; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; SODIUM, DIETARY; SUPPORT, NON-U.S. GOV'T; SYMPATHETIC NERVOUS SYSTEM; XYLAZINE; YOHIMBINE;

EID: 0034648235     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(00)00093-X     Document Type: Article

References (24)

1. Aisenbrey G., Berl T. Role of vasopressin in the control of systemic hemodynamics - lessons learned from the Brattleboro rat. Ann. NY Acad. Sci. 394:1982;299-307.
2. 2A-adrenergic receptor-like immunoreactivity. Brain. Res. 650:1994;181-204.
3. Blandford D.E., Smyth D.D. Dose selective dissociation of water and solute excretion after renal alpha-2 adrenoceptor simulation. J. Pharmacol. Exp. Ther. 247:1988;1181-1186.
4. Bousquet P., Feldman J. The blood pressure effects of alpha-adrenoceptor antagonists injected in the medullary site of action of clonidine: The nucleus reticularis lateralis. Life Sci. 40:1987;1045-1052.
5. Brooks D.P., Edwards R.M., Depalma P.D., Fredrickson T.A., Hieble J.P., Gellai M. The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependent. J. Pharmacol. Exp. Ther. 259:1991;1277-1282.
6. Cabral A.M., Varner K.J., Kapusta D.K. Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats. J. Pharmacol. Exp. Ther. 282:1997;609-616.
7. Cabral A.M., Gardioli C.R., Mauad H., Vasquez E.C. Diverse effects of renal denervation on ventricular hypertrophy and blood pressure in DOCA-salt hypertensive rats. Braz. J. Med. Biol. Res. 31:1998;587-590.
8. 2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia. Am. J. Physiol. 275:(44):1998;RI867-RI874.
9. Cabral A.M., Musso M.N., Bissoli N.S., Carvalhinho F.B., Vasquez E.C. Chlorthalidone reduces vascular hyperresponsiveness in DOCA-salt hypertensive rats. Clin. Exp. Hypertens. 14:1992;667-683.
10. Dawson R. Jr., Wallace D. Central and peripheral actions of alpha-2 adrenergic agonists on renal function in Long-Evans and Brattleboro rats. Pharmacology. 39:1989;240-252.
11. de Champlain J., Farley L., Cousineau D., van Ameringen M.R. Circulating catecholamine level in human and experimental hypertension. Circ. Res. 38:1976;109-114.
12. 2 adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134:1987;1-13.
13. Gehr M., MacCarhy E.P., Goldborg M. Guanabenz: a centrally acting, natriuretic antihypertensive drug. Kidney Int. 29:1986;1203-1208.
14. Head G.A., Korner P.I., Lewis S.L., Badoer E. Contribution of noradrenergic neurons to the circulatory effects of centrally acting clonidine and alpha-methyldopa in rabbits. J. Cardiovasc. Pharmacol. 5:(6):1983;945-953.
15. Isaac L. Clonidine in the central nervous system: Site and mechanism of hypotensive action. J. Cardiovasc. Pharmacol. 2:1980;S5-S19.
16. Katholi R.E., Naftilan A.J., Oparil S. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat. Hypertension. 2:1980;266-273.
17. Kline R.L., Mercer P.F. Contribution of renal nerves to the natriuretic and diuretic effect of alpha-2 adrenergic receptor activation. J. Pharmacol. Exp. Ther. 253:1990;266-271.
18. Koepke J.P., DiBona G.F. Central adrenergic receptor control of renal function in conscious hypertensive rats. Hypertension. 8:1986;133-141.
19. Kopp U.C., DiBona G.F. The neural control of renal function. Seldin D.W., Giebisch G. The Kidney: Physiology and Pathophysiology. 2nd Edition :1992;1157-1204 Raven Press, New York.
20. Krothapalli R.K., Suki W.N. Functional characterization of the alpha adrenergic receptor modulating the hydrosmotic effect of vasopressin on the rabbit cortical collecting tubule. J. Clin. Invest. 73:1984;740-749.
21. 2-receptors in rostral ventrolateral medulla (RVLM) produce natriuresis in ketamine-anesthetized rats by a renal nerve-dependent mechanism. Soc. Neurosci. Abstr. 23:1997;723.
22. Reid J.L., Zivin J.A., Kopin I.J. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats. Circ. Res. 37:1975;569-579.
23. Share L., Crofton J.T. Contribution of vasopressin to hypertension. Hypertension. 4:1982;11185-11192.
24. Swanson K.L.W., Sawchenko P.E. Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei. Annu. Rev. Neurosci. 6:1983;269-324.